EFPIA - NEWSLETTER

Trouble reading this email? View it in your browser


		EFPIA Newsletter 2 April 2026

News

EFPIA statement on the conclusions of the EU-India Free Trade Agreement (FTA) negotiations
31 March 2026

EFPIA welcomes the EU’s continued efforts to strengthen trade ties with strategic partners at a time of growing geopolitical... Read more

Blogs

When Chemical policy meets patient care: Why the PFAS debate needs a closer look at medicines...
30 March 2026

Europe is in the middle of one of the most ambitious chemical regulatory debates in its history. Read more

POLITICO’s Competitive Europe Summit: watch the event recording

OPENING REMARKS by Stefan Oelrich, President of EFPIA and Pharmaceuticals at Bayer AG | POLITICO

On 24 March, EFPIA took part in POLITICO’s Competitive Europe Summit, at a pivotal moment for Europe’s future. With... Read more

FIRESIDE CHAT | Health: Can Europe lead the world’s Pharma market? | POLITICO

In a fireside chat on Europe’s global competitiveness in pharmaceuticals, Padraic Ward, Head of Roche Pharma... Read more

Europe’s Choice: Investing in sustainable health systems | 21 April

European health and social care systems are under intense pressure.

With strained budgets, growing pressure on public finances, a deepening workforce crisis, and an uncertain geopolitical landscape, the need to rethink healthcare in Europe has never been more urgent.

Join us on 21 April to discuss how Health Checks for cardiometabolic risk factors can transform prevention, reduce avoidable disease, and lower long-term costs.

Discover the programme and register here.

What we are reading

Drugmakers delay some European launches with a wary eye on Trump's pricing policies
On 31 March 2026 (Reuters)

Drugmakers are delaying launches of some new medicines in Europe as the industry grapples with U.S. pressure and... Read more

Europe’s wastewater Rubik’s Cube: Can Commission and industry align data?
On 27 March 2026 (Euractiv)

Safeguarding Europe’s water quality has become an increasingly fraught policy challenge as regulators attempt to... Read more

Czech minister warns EU, wastewater rules risk limiting medicines access
On 27 March 2026 (Euractiv)

Prague calls on the European Commission and member states to reconsider environmental obligations amid fears of medicine... Read more

The Most Favored Nation Policy: early insights into Europe’s response
On 25 March 2026 (Pharmaceutical Technology)

GlobalData analysed the product launch and withdrawal trends using its Price Intelligence (POLI) database, comparing... Read more

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
E-mail:Communications@efpia.eu